Isatuximab monotherapy in patients with refractory T‐acute lymphoblastic leukemia or T‐lymphoblastic lymphoma: Phase 2 study
暂无分享，去创建一个
P. Chevallier | X. Thomas | G. Rossi | N. Boissel | L. Griškevičius | G. Abbadessa | A. Rambaldi | A. Maschan | S. Macé | A. Sokolov | C. Oprea | V. Doronin | U. Wartiovaara-Kautto | A. Gosselin | J. Mccloskey